Q-linea today announces that clinical insights from two prospective studies will be presented at the AMCLI congress. Data will be shared both from the largest comparative study performed in
At the upcoming conference, AMCLI (Associazione Microbiologi Clinici Italiani) National
- Prof. Alexia Verroken, from
Cliniques Universitaires Saint-Luc ,Brussels , will present the results of a trial investigating the clinical impact of rapid AST on positive blood cultures from 200 patients with bacteremia. The study is a comparative analysis of Q-linea’s ASTar system with two other rapid AST technologies, providing insights into user-friendliness, performance, and clinical impact of each approach.
- Prof.
Maurizio Sanguinetti , from Universitá Cattolica del Sacro Cuore,Rome , will present interim data from the ongoing Lifetimes health economics study, including 160 prospective ICU patients with bloodstream infections.
“It is an honor to present ASTar for the first time at this national conference, alongside these distinguished speakers. The workshop will offer a unique opportunity to showcase ASTar’s clinical impact in real-life scenarios,” said Dr.
"I look forward to see the results from the largest comparative study between rapid AST systems performed in
© Modular Finance, source